PT-141 in Houston, for desire — not just function.
PT-141 (bremelanotide) addresses sexual desire through brain pathways — a different solution than PDE-5 inhibitors, for a different problem.
A treatment for desire, not just function.
PT-141 (bremelanotide) is a peptide that works on the brain’s desire pathways rather than on blood flow. Unlike sildenafil or tadalafil, which improve erectile mechanics in men with normal libido, PT-141 directly stimulates the melanocortin receptors involved in sexual arousal and desire. The result is increased interest, responsiveness, and sexual function — for both men and women.
PT-141 was FDA-approved in 2019 under the brand name Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD). It’s prescribed off-label for men with desire-specific concerns and for women outside the FDA-approved indication when clinically appropriate. The medication is administered as a subcutaneous injection roughly 45 minutes before sexual activity, with effects lasting 6 to 8 hours.
What makes PT-141 distinct is that it addresses a different problem than the PDE-5 inhibitors. If erectile mechanics work but the spark isn’t there — if desire has flattened, if interest has disappeared, if intimacy feels disconnected from physical response — PT-141 may be the right conversation. Sildenafil and tadalafil don’t fix desire; PT-141 might.
When desire is the missing piece, not mechanics.
PT-141 isn’t for everyone with sexual concerns. It’s specifically useful when the issue is desire rather than function. Here’s how we think about who’s a good candidate.
Erections work, desire doesn’t
Men whose erectile mechanics are intact but who’ve lost interest in sex over the past months or years. Often men on adequate TRT with normal testosterone whose libido still hasn’t returned. PT-141 addresses the central desire pathways that testosterone alone may not reach.
Best for: Libido without ED · Post-TRT desire gap · Off-label useHSDD — desire that’s gone
FDA-approved for premenopausal women with hypoactive sexual desire disorder — persistent low desire causing personal distress, not explained by other medical or psychological conditions. Also used off-label for postmenopausal women whose desire hasn’t responded to hormone replacement.
Best for: HSDD · Post-HRT desire gap · Female libidoWith hormones, with PDE-5s
For patients whose desire is multifactorial. Often combined with TRT for men or HRT for women, addressing both hormonal foundation and desire pathways. Sometimes combined with PDE-5 inhibitors in men who have both libido and mechanical concerns — different problems, different solutions, used together.
Best for: Layered protocols · Multifactorial concerns · Combined therapyLibido is rarely about libido. Most of the time it’s about everything else.
PT-141 addresses one specific pathway. But desire depends on energy, sleep, hormones, stress, mental health, and relationship dynamics. The patients who do best are the ones who address the whole picture, not just the medication.
The medication can light the spark. The foundations make it sustainable.
Patients who use PT-141 successfully tend to have addressed the broader picture. That’s not because PT-141 doesn’t work otherwise — it just works better when the underlying conditions for desire are in place.
- Hormonal foundation — for men, optimized testosterone; for women, appropriate HRT when in the right window
- Sleep and stress — chronic poor sleep and elevated cortisol both crush libido at the source
- Mental and relational context — desire isn’t just biology; stress, depression, anxiety, and relationship dynamics matter
- For erectile mechanics specifically, sildenafil or tadalafil address a different problem
From consultation to first prescription, in real medicine.
PT-141 is a powerful medication that addresses a specific question. The process matches that specificity.
Initial consultation
In person at our Houston clinic. We discuss what’s actually going on — desire vs. mechanics, when changes started, what’s been tried, current medications, hormonal status, and relationship context. We’re honest about whether PT-141 is the right tool or whether the conversation should be about something else first.
Focused workup
Lab work to rule out competing causes — testosterone (men), full hormone panel (women), thyroid, A1c, vitamin D, ferritin. Medication review for known libido-affecting drugs. Cardiovascular screening, since PT-141 can transiently raise blood pressure.
Protocol design
Compounded PT-141 prepared by our partner pharmacies. Starting dose typically 1.0–1.75 mg subcutaneous, taken roughly 45 minutes before anticipated sexual activity. Clear instructions on dosing, timing, and what to expect — including realistic expectations about response variability.
First prescription
Compounded PT-141 shipped from licensed compounding pharmacy. Includes injection supplies and detailed administration instructions. We’re available for questions about timing, dosing, or any side effects during the early use phase.
Follow-up & adjustment
Brief follow-up to assess response and tolerability. PT-141 dosing often needs individualization — some patients respond well to 1.0 mg, others need 1.75 mg or higher. If response is inadequate or side effects are limiting, we adjust. If PT-141 isn’t the right answer, we have an honest conversation about what else might be.
Ready to start the conversation?
A 45-minute consultation with one of our physicians. We’ll figure out together whether PT-141 is the right tool for your specific situation, and what else may need to be part of the picture.
What PT-141 can — and can’t — do.
PT-141 is genuinely useful for the right patient. It’s also more variable in response than the PDE-5 inhibitors, and the framing matters.
What PT-141 can do
- Increase sexual desire and interest in responders
- Work for both men and women
- Help in cases where hormone optimization alone hasn’t restored libido
- Combine well with PDE-5 inhibitors when both desire and mechanics are concerns
- Combine well with TRT or HRT as part of a layered protocol
- Be used on-demand without daily commitment
- Provide a 6-8 hour window of increased responsiveness from a single dose
What PT-141 can’t do
- Produce dramatic results in every patient — response is more variable than PDE-5 inhibitors
- Fix relationship issues, depression, or stress-driven libido changes
- Substitute for proper hormonal workup when low T or hormone imbalance is the underlying issue
- Be appropriate for patients with uncontrolled hypertension or cardiovascular concerns
- Avoid all side effects — nausea is the most common, sometimes significant enough to limit use
- Work for everyone — some patients try it and don’t experience a meaningful response
Before you book.
How much does treatment cost?
The initial consultation is $349. Compounded PT-141 typically runs $200 to $400 per month depending on dosing and frequency. The FDA-approved version (Vyleesi) for women can be substantially more expensive when not covered by insurance. Our clinical service fees cover physician oversight, lab review, and follow-up separately. We’ll discuss specifics during consultation.
How is PT-141 different from sildenafil or tadalafil?
They address completely different problems. Sildenafil and tadalafil are PDE-5 inhibitors that improve blood flow for erections — they help with mechanics. PT-141 works on the brain’s desire pathways through melanocortin receptors — it helps with interest and arousal. Some patients need one, some need the other, and some benefit from both. If your erectile mechanics work but you’ve lost interest, PT-141 may be the right answer. If you have interest but mechanics aren’t responding, sildenafil or tadalafil are.
What are the side effects?
The most common side effect is nausea, particularly with the first few doses. About 40% of users experience some nausea, though it tends to improve with continued use or with timing adjustments (taking on an empty stomach can make it worse). Other common effects include flushing, headache, and a temporary rise in blood pressure. Some users notice darkening of skin or freckles with frequent use — usually subtle and reversible. Serious side effects are rare.
Is PT-141 FDA-approved?
Yes, for premenopausal women with hypoactive sexual desire disorder, under the brand name Vyleesi. It’s prescribed off-label for men and for women outside that specific indication. Off-label prescribing is standard medical practice when there’s clinical evidence supporting the use — sildenafil for women, tadalafil for BPH, and many other medications are commonly used off-label. We discuss the off-label nature openly during consultation.
How does it actually work?
PT-141 activates melanocortin receptors (specifically MC3R and MC4R) in the central nervous system. These receptors play a role in sexual arousal pathways, regulating both desire and physical sexual response. Unlike PDE-5 inhibitors, which require sexual stimulation to work, PT-141 can produce direct increases in arousal. The exact downstream mechanisms are still being studied, but the clinical effect is reasonably well-characterized.
Can I use it with TRT or HRT?
Yes, and many patients do. The combination makes clinical sense for patients whose hormonal foundation is optimized but who still experience desire concerns. TRT or HRT addresses the hormonal infrastructure for desire; PT-141 addresses the central pathways that the hormones don’t fully reach. We often layer them, particularly for patients on stable hormone protocols who still feel something is missing.
What if it doesn’t work for me?
Response varies, and not everyone responds to PT-141. If you’ve tried two or three doses without meaningful effect, we have an honest conversation about whether to adjust the dose, try a different timing, or step back and consider that PT-141 may not be the right tool for your specific situation. We don’t keep prescribing if it’s not working. Sometimes the answer is addressing a different piece of the picture — sleep, hormones, mental health, or relationship dynamics.
Start with a conversation, not a prescription.
A 45-minute consultation with one of our Houston physicians. We’ll figure out what’s actually going on, what’s worth trying, and whether PT-141 fits your specific situation.